fluoxetine has been researched along with sincalide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brambilla, F; Brunetta, M; Manfredi, B; Panerai, AE; Peirone, A; Perna, G; Sacerdote, P | 1 |
| Bagdy, G; To, CT | 1 |
1 review(s) available for fluoxetine and sincalide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for fluoxetine and sincalide
| Article | Year |
|---|---|
T-lymphocyte cholecystokinin-8 and beta-endorphin concentrations in eating disorders: I. Anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Antidepressive Agents; beta-Endorphin; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzocycloheptenes; Female; Fluoxetine; Humans; Nortriptyline; Sincalide; T-Lymphocytes; Treatment Outcome | 1995 |
2 other study(ies) available for fluoxetine and sincalide
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cerebral Ventricles; Drug Administration Schedule; Fluoxetine; Grooming; Injections, Intraperitoneal; Injections, Intraventricular; Male; Motor Activity; Pyrimidines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sincalide; Social Behavior | 1999 |